Agarwal, T., Annamalai, N., Ronanki, H. P., Butty, S., Maiti, T. K., & Arsad, H. B. (2018). MUTANT P21 PEPTIDES COULD ACT AS AN IMPROVED CYCLIN A INHIBITORS FOR CANCER THERAPY: AN IN SILICO VALIDATION. International Journal of Pharmacy and Pharmaceutical Sciences, 11(2), 59-64. https://doi.org/10.22159/ijpps.2019v11i2.30577